Saba Sile

Saba Sile, MD has worked in the healthcare industry since 2008. Her work experience includes roles as Director of Clinical Sciences at BioMarin Pharmaceutical Inc. from 2008 to 2013, Clinical Attending in the Nephrology Division at UCSF Health from 2008 to 2016, Director of Clinical Research in the Cardiovascular Therapeutic Area at Gilead Sciences from 2013 to 2016, and Executive Medical Director at Horizon from 2016 to 2022. In 2022, they will take on two new roles as VP Clinical Development at Spruce Biosciences and Attending Physician in Internal Medicine/Nephrology (Volunteer) at Roots Community Health Center.

Saba Sile, MD completed their Doctor of Medicine - MD at the University of Pittsburgh School of Medicine. Saba then completed an Internal Medicine Residency Program at The University of Tennessee Health Science Center. Afterwards, they completed a Nephrology Fellowship at Vanderbilt University School of Medicine. Additionally, they obtained a California Medical License from the California state license in November 2008, and is expected to complete the Horizon Enterprise Leadership Development Program at Harvard Business School in August 2022.